JMM Correspondence
Multidrug-resistant Mycobacterium tuberculosis Beijing/W genotype in Venezuela Mycobacterium tuberculosis Beijing/W family, described in 1995 (van Soolingen et al., 1995) , is an emerging pathogen in several areas of the world, and a predominant endemic strain in others; it is frequently associated with drug resistance (European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis, 2006) . However, in Latin America little information about the prevalence of this genotype is available. Cuba and Argentina have reported Beijing genotype-infected patients, but only in Cuba has an association been found with drug resistance (Díaz et al., 1998; Morcillo et al., 2005) .
In Venezuela, a country of moderate tuberculosis (TB) incidence (25 per 100 000 population), the first countrywide study of drug resistance was carried out during 1998-1999. The majority (77 %) of the strains isolated in this survey were genotyped by spoligotyping and the Beijing/W genotype was not found (Aristimuño et al., 2006) .
In this study we investigated the genetic profiles of a collection of 36 multidrug-resistant (MDR) M. tuberculosis isolates, cultured from smear-positive sputum of 36 TB cases diagnosed by the Venezuelan National Tuberculosis Programme (VNTP), during the period 2000-2004. The isolates were identified as M. tuberculosis complex using biochemical tests, and drug susceptibility testing (DST) was carried out on Lowenstein-Jensen medium by the proportion method (Canetti et al., 1969) and the BACTEC 460 radiometric method (Siddiqi et al., 1981) . Extraction of genomic DNA, spoligotyping and IS6110-RFLP were performed by standard methods (Ausubel et al., 1988; Kamerbeek et al., 1997; van Embden et al., 1993) . (Codina et al., 1999) (Fig. 1) .
The 3748 Beijing/W strain was isolated from a 37-year-old Peruvian, human immunodeficiency virus (HIV)-negative male, resident in Caracas, Venezuela, who used to travel to and from Lima, Peru. He had been diagnosed with pulmonary TB and received non-supervised treatment. He emigrated to Venezuela with respiratory symptoms, in 2002, and received standard retreatment (VNTP); however, he was not cured and died 2 years later.
The 4145 Beijing/W strain was isolated from a 17-year-old Venezuelan, HIVnegative male, diagnosed with pulmonary TB in 2002, and resident in Caracas, who declared no travel abroad. He had not previously received anti-TB treatment and received the standard treatment for new TB cases, according to VNTP. However, his sputum was not cleared. He was then treated with a regimen that included amikacin, pyrazinamide, cycloserine, ethionamide and ofloxacin, but again the sputum was not cleared.
The VNTP prescribes for all forms of TB, with or without culture confirmation, a standardized 6 month treatment for all new TB cases, consisting of a 2 month initial phase of INH, RIF, pyrazinamide and ethambutol, followed by a phase of 4 months with INH and RIF three times a week. If a patient is not cured with this regimen the VNTP indicates culture and DST. The regimen with second line drugs is prescribed in accordance with the results of the DST.
In summary, the findings in this study document for what is believed to be the first time a cluster of two TB patients infected by Beijing/W genotype MDR strains in Venezuela. The high similarity observed with the fingerprints of the isolates from Peruvian immigrant patients resident in Spain suggest that the first Fig. 1 
